10:03 AM EST - The Yield Growth Corp. : Announced that it’s subsidiary Flourish Mushroom Labs Inc. has entered into an agreement to acquire approximately 18% of the outstanding stock of Translational Life Sciences Inc. (“TLS”). TLS aims to develop proprietary formulations using restricted substances to focus on unmet medical needs in opioid dependence, psychotic illness, pain management and traumatic brain injury, including concussion. The company also offers services to design and oversee clinical trials of restricted substances such as psilocybin based formulations for third parties. The Yield Growth Corp.
shares BOSS:CNX are trading up 1.75 percent at $0.29.
